Does EVEROLIMUS Cause Dyslipidaemia? 80 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 80 reports of Dyslipidaemia have been filed in association with EVEROLIMUS (EVEROLIMUS). This represents 0.2% of all adverse event reports for EVEROLIMUS.
80
Reports of Dyslipidaemia with EVEROLIMUS
0.2%
of all EVEROLIMUS reports
3
Deaths
24
Hospitalizations
How Dangerous Is Dyslipidaemia From EVEROLIMUS?
Of the 80 reports, 3 (3.8%) resulted in death, 24 (30.0%) required hospitalization, and 11 (13.8%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for EVEROLIMUS. However, 80 reports have been filed with the FAERS database.
What Other Side Effects Does EVEROLIMUS Cause?
Death (5,090)
Malignant neoplasm progression (3,789)
Diarrhoea (3,061)
Fatigue (2,946)
Stomatitis (2,692)
Nausea (2,079)
Dyspnoea (1,925)
Drug ineffective (1,837)
Pyrexia (1,664)
Decreased appetite (1,633)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ROSUVASTATIN (206)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
Which EVEROLIMUS Alternatives Have Lower Dyslipidaemia Risk?
EVEROLIMUS vs EVOLOCUMAB
EVEROLIMUS vs EXELON
EVEROLIMUS vs EXEMESTANE
EVEROLIMUS vs EXENATIDE
EVEROLIMUS vs EXFORGE